Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of AstraZeneca's Zibotentan?
Zibotentan is a small molecule commercialized by AstraZeneca, with a leading Phase II program in Liver Cirrhosis. According to Globaldata,...
Zibotentan by AstraZeneca for Microvascular Angina: Likelihood of Approval
Zibotentan is under clinical development by AstraZeneca and currently in Phase II for Microvascular Angina. According to GlobalData, Phase II...
Zibotentan by AstraZeneca for Liver Cirrhosis: Likelihood of Approval
Zibotentan is under clinical development by AstraZeneca and currently in Phase II for Liver Cirrhosis. According to GlobalData, Phase II...
Zibotentan by AstraZeneca for Diabetic Nephropathy: Likelihood of Approval
Zibotentan is under clinical development by AstraZeneca and currently in Phase II for Diabetic Nephropathy. According to GlobalData, Phase II...